- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Poll: Is Enough Being Done to Reduce Dose?
From new technologies to awareness campaigns, the radiology industry has taken great strides to address concerns about radiation dose. Is it enough?
From adopting new technologies to updating protocols, the radiology industry has taken great strides in recent years to address concerns about radiation dose. Imaging professionals are pledging to increase awareness among peers and patients, and a recent study even examines the possibility of an antioxidant pill protecting patients from radiation-induced cancer.
Is the industry doing enough to reduce dose? What else can be done?
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
